Navigation Links
CMC Biologics Honored as Finalist for Washington's Manufacturing Company of the Year Award
Date:5/3/2012

SEATTLE, May 3, 2012 /PRNewswire/ -- CMC Biologics, a leading contract manufacturing organization (CMO) known and respected for its technical excellence in process development and cGMP manufacture, has been named a finalist for  the 2012 Manufacturing Company of the Year – Large Category.   The Seattle Business Magazine's Washington Manufacturing Awards, in partnership with Impact Washington, brought together nearly 300 leaders in manufacturing from around the state.

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO )

"CMC Biologics has been operating in Washington state as a thriving biopharmaceutical contract manufacturer since 2007.  With nearly 450 talented and hardworking employee's world-wide, we continue to grow and to hire locally and globally at our manufacturing facility in Bothell, as well as our facility in Copenhagen, Denmark," said Gustavo Mahler, Chief Operations Officer for the company. "We are positioned to be the leader among CMO's in customer satisfaction and technical excellence, and are excited to be considered a top manufacturer among dozens of companies in this competition."

"The life sciences industry is one of the fastest growing economic drivers of our state, and companies like CMC Biologics as a biopharmaceutical manufacturer, are providing the people of Washington with good jobs and a prosperous future," stated Gubernatorial Candidate Jay Inslee.  "I'd like to congratulate the team at CMC Biologics for their hard work and dedication as a finalist for Washington's Manufacturer of the Year."

As the state's largest biopharmaceutical manufacturer, CMC Biologics' contribution to the economy is significant.  In 2011, CMC Biologics completed the expansion of a state-of the art stainless steel biopharmaceutical manufacturing facility, utilizing local contractors and suppliers.  This expansion added significant production capacity to accommodate growing demand for cGMP commercial manufacture of biopharmaceuticals and to support commercial manufacturing and was the second stage of a major manufacturing expansion plan that started with the construction of a multi‑purpose single-use facility completed in 2010.

About CMC Biologics

CMC Biologics is a leading contract development and manufacturing organization that provides fully integrated biopharmaceutical development and manufacturing solutions to clients around the world, from its facilities in Europe and the USA.  The company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials and in-market production.  The company's wide range of integrated services includes cell line development, bioprocess development, formulation and comprehensive analytical testing.  Clients can also benefit from CMC Biologics' proprietary CHEF1® expression system for mammalian production.  CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.  CMC Biologics is located in Copenhagen, Denmark, and Seattle, Washington. Visit www.cmcbio.com  to learn more.

 

 


'/>"/>
SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
2. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Savient Submits Biologics License Application (BLA) for pegloticase
5. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
6. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
7. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
8. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
9. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
10. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
11. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... Vixiar Medical announced today that ... functions to The LaunchPort™ Accelerator at the City Garage in Port Covington. The ... and business services to its Residents. , Vixiar Medical recently closed a ...
(Date:9/21/2017)... (France) , ... (PRWEB) September 21, 2017 , ... ... an international scientific and technical congress to review the latest knowledge on these ... of prestigious international speakers will discuss the impact of Biostimulants on Plant Nutrition, ...
(Date:9/21/2017)... London UK (PRWEB) , ... September 21, 2017 ... ... , a QuintilesIMS company, who enable the world’s most progressive pharma and biotech ... 2,000 clinical trials at top pharma and biotech events in Q4. , DrugDev ...
(Date:9/21/2017)... ... September 21, 2017 , ... When a ... the response was swift and efficient thanks to the continuing efforts of members ... up of more than 50 stakeholders, including officials from area counties and cities, ...
Breaking Biology Technology:
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
Breaking Biology News(10 mins):